SCHEMBL6804785

SCHEMBL6804785

CCOc1cc(-c2ccccc2)nn1CCOc1ccc(-c2ccccc2F)cc1Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.38
MDM2 Q00987 3/20 0.38
HPGD P15428 1/20 0.38
CREBBP Q92793 1/20 0.37
S1PR4 O95977 1/20 0.36
MAPT P10636 2/20 0.36
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
RAB9A P51151 1/20 0.35
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
LTB4R Q15722 1/20 0.35
SLC6A9 P48067 1/20 0.35
CTSA P10619 1/20 0.35
FAAH O00519 1/20 0.35
KMT2A Q03164 1/20 0.34
EIF4EBP1 Q13541 2/20 0.34
GCGR P47871 1/20 0.34
GIPR P48546 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6805285 0.92 TP53 (0.49) TP53MDM2MAPTALDH1A1KDM4E
SCHEMBL6603655 0.89 HPGD (0.38) TP53MDM2HPGDCREBBPS1PR4
SCHEMBL6607860 0.89 HPGD (0.40) TP53MDM2HPGDCREBBPS1PR4
SCHEMBL6602658 0.89 HPGD (0.42) TP53MDM2HPGDCREBBPS1PR4
SCHEMBL6600937 0.89 TP53 (0.41) TP53MDM2MAPTALDH1A1KDM4E
SCHEMBL6805998 0.87 HPGD (0.41) TP53MDM2HPGDCREBBPS1PR4
SCHEMBL6809196 0.86 TP53 (0.46) TP53MDM2MAPTALDH1A1KDM4E
SCHEMBL6604163 0.84 S1PR4 (0.40) TP53MDM2HPGDCREBBPS1PR4
SCHEMBL6809221 0.84 MEN1 (0.41) TP53MDM2MAPTALDH1A1KDM4E
SCHEMBL6805954 0.84 MRGPRX4 (0.38) HPGDCREBBPS1PR4MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040180891-A1 Pyrazole derivatives useful in the treatment of hyper-proliferative disorders BAYER PHARMACEUTICALS CORPORATION 2004-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040180891-A1 Pyrazole derivatives useful in the treatment of hyper-proliferative disorders MKI67, CDK4, FLT4 TP53 35/4885MDM2 1509/4885HPGD 76/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.